Xspray Pharma: Additional positive XS003 data - Redeye
Redeye leaves its comments on Xspray following a press release confirming that XS003 shows matching bioavailability to Tasigna at a more than 50% lower dose.
ANNONS
Redeye leaves its comments on Xspray following a press release confirming that XS003 shows matching bioavailability to Tasigna at a more than 50% lower dose.